Sharp Edge Labs

Technology
Biotechnology

Sharp Edge Labs is developing next generation biosensors based on the Fluorogen Activating Peptide technology of co-Founders Alan Waggoner and Marcel Bruchez

Suggest edits

Founded

2011

Raised

$600k

Follow us

Also headquartered in Pittsburgh

Vivo
Duolingo
Carnegie Mellon
Alcoa Inc.
JazzHR
Dynamics Inc
Avere Systems
American Eagle
Argo AI
CONSOL Energy

Companies in the same industry

Molecular Matrix
Ageria
Aspyrian Therapeutics
French Accelerator
Syntimmune
Prometic
AccessBio Korea
Noveome
Amarillo Biosciences Inc
BioCancell

Alexa global traffic share

Index

By TNW

Sharp Edge Labs

Sharp Edge Labs